A new fast-melting oral formulation of desmopressin: A pharmacodynamic study in children with primary nocturnal enuresis

BJU International

Volumn 97, Issue 3, 2006, Pages 603-609

  Vande Walle, Johan G J ^a,h   Bogaert, Guy A ^b   Mattsson, Sven ^c   Schurmans, Thierry ^d   Hoebeke, Piet ^a   Deboe, Veerle ^e   Norgaard, Jens Peter ^f,g  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c LINKÖPING UNIVERSITY   (Sweden)

^d HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^e VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^f Ferring Pharmaceuticals AS   (Denmark)

^g LUND UNIVERSITY   (Sweden)

^h GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Children; Desmopressin; Osmolality; Pharmacodynamics; Primary nocturnal enuresis

Indexed keywords

DESMOPRESSIN; PLACEBO; VASOPRESSIN;

ANTIDIURESIS; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DIURESIS; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HORMONE SYNTHESIS; HUMAN; HYDRATION; KIDNEY CONCENTRATING CAPACITY; LYOPHILISATE; MALE; NIGHT SLEEP; NOCTURNAL ENURESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT; URINE OSMOLALITY; URINE VOLUME;

ADMINISTRATION, ORAL; ANTIDIURETIC AGENTS; CHILD; DEAMINO ARGININE VASOPRESSIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENURESIS; FEMALE; HUMANS; MALE; OSMOLAR CONCENTRATION; TREATMENT OUTCOME;

EID: 33645015898     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.05999.x     Document Type: Article

References (15)

1. Hellstrom AL Hanson E Hansson S Hjalmas K Jodal U Micturition habits and incontinence in 7-year-old Swedish school entrants Eur J Pediatr 1990 149 434 7
2. Norgaard JP Djurhuus JC Watanabe H Stenberg A Lettgen B Experience and current status of research into the pathophysiology of nocturnal enuresis Br J Urol 1997 79 825 35
3. Hjalmas K Arnold T Bower W et al. Nocturnal enuresis: an international evidence-based management strategy J Urol 2004 171 2545 61
4. Norgaard JP van Gool JD Hjalmas K Djuurhuus JC Hellstrom AL Standardisation and definitions in lower urinary tract dysfunction in children. International Children's Continence Society. BJU Int 1998 81 Suppl. 3 1 16
5. Norgaard JP Pedersen EB Djurhuus JC Diurnal anti-diuretic-hormone levels in enuretics J Urol 1985 134 1029 31
6. Eller DA Homsy YL Austin PF Tanguay S Cantor A Spot urine osmolality, age and bladder capacity as predictors of response to desmopressin in nocturnal enuresis Scand J Urol Nephrol Suppl 1997 183 41 5
7. Neveus T Lackgren G Tuvemo T Hetta J Hjalmas K Stenberg A Enuresis - background and treatment Scand J Urol Nephrol Suppl 2000 206 1 44
8. Dehoorne J Vande Walle J Raes A et al. Prolonged half life of DDAVP spray in 18 patients with MNE ICCS Biennual Meeting, Het PandGent 17-18/9/2004 (abstract 28 poster
9. Hjalmas K SWEET, the Swedish Enuresis Trial Scand J Urol Nephrol Suppl 1995 173 89 93
10. Wolfish NM Barkin J Gorodzinsky F Schwarz R The Canadian Enuresis Study and Evaluation - short- and long-term safety and efficacy of an oral desmopressin preparation Scand J Urol Nephrol 2003 37 22 7
11. Schulman SL Stokes A Salzman PM The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis J Urol 2001 166 2427 31
12. European legislation. EEC 1768/92, directive 2001/83/EC and regulation EC 726. Brussels: EU 2004
13. FDA. Best Pharmaceuticals for Children Act FDA Regulation January 4, 2002. Available at. Accessed October 2005
14. Norgaard JP Hansen JH Nielsen JB Rittig S Djurrhuus JC Nocturnal studies in enuretics. A polygraphic study of sleep-EEG and bladder activity Scand J Urol Nephrol Suppl 1989 125 73 8
15. Aceto G Penza R Coccioli MS et al. Enuresis subtypes based on nocturnal hypercalciuria: a multicenter study J Urol 2003 170 1670 3